Concurrent vaccinations against PCV2 and PRRSV: Study on the specific immunity and clinical protection in naturally infected pigs

Veterinary Microbiology

Volumn 162, Issue 2-4, 2013, Pages 558-571

  Martelli, Paolo ^a   Ardigò, Paolo ^a   Ferrari, Luca ^a   Morganti, Marina ^a   De Angelis, Elena ^a   Bonilauri, Paolo ^b   Luppi, Andrea ^b   Guazzetti, Stefano ^c   Caleffi, Antonio ^d   Borghetti, Paolo ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b IZSLER   (Italy)

^c PATHOLOGY UNIT   (Italy)

^d Vet Practitioner   (Italy)

Author keywords

Clinical protection; Immune response; Porcine circovirus type 2 (PCV2); Porcine reproductive and respiratory syndrome virus (PRRSV); Vaccine efficacy

Indexed keywords

ARTERIVIRUS VACCINE; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; MATERNAL ANTIBODY; PORCINE CIRCOVIRUS TYPE 2 VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIVIRUS; ARTERIVIRUS INFECTION; ARTICLE; CELLULAR IMMUNITY; CIRCOVIRIDAE INFECTION; CIRCOVIRUS; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; MORTALITY; NONHUMAN; PORCINE CIRCOVIRUS TYPE 2; PROBABILITY; SCORING SYSTEM; SEROCONVERSION; SWINE; VACCINATION; VIREMIA; VIRUS LOAD; WEIGHT GAIN;

ANIMALS; ANTIBODIES, VIRAL; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; FEMALE; IMMUNITY, CELLULAR; INJECTIONS, INTRAMUSCULAR; ITALY; MALE; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; PROPORTIONAL HAZARDS MODELS; SUS SCROFA; SWINE; VACCINATION; VACCINES, ATTENUATED; VIRAL VACCINES; VIREMIA; WEIGHT GAIN;

ANIMALIA; PORCINE CIRCOVIRUS 2; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUIDAE;

EID: 84872499407     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2012.11.016     Document Type: Article

References (51)

1. Allan G.M., McNeilly F., Meehan B.M., Kennedy S., Mackie D.P., Ellis J.A., et al. Isolation and characterisation of circoviruses from pigs with wasting syndromes in Spain, Denmark and Northern Ireland. Vet. Microbiol. 1999, 66:115-123.
2. Allan G.M., McNeilly F., Ellis J., Krakowka S., Meehan B., McNair I., et al. Experimental infection of colostrum deprived piglets with porcine circovirus 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) potentiates PCV2 replication. Arch. Virol. 2000, 145:2421-2429.
3. Blanchard P., Mahe D., Cariolet R., Keranflec'h A., Baudouard M.A., Cordioli P., et al. Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine 2003, 21:4565-4575.
4. Bonilauri P., Bonci M., Merialdi G., Dottori M. Development and validation of real time (FRET probe) PCR for detection of PRRSV (EU). Proceedings of the 5th International Symposium on Emerging and Re-emerging Pig Diseases 2007, 194.
5. Chae C. Postweaning multisystemic wasting syndrome: a review of aetiology, diagnosis and pathology. Vet. J. 2004, 168:41-49.
6. Chand R.J., Trible B.R., Rowland R.R. Pathogenesis of porcine reproductive and respiratory syndrome virus. Curr. Opin. Virol. 2012, 2:256-263.
7. Cline G., Wilt V., Diaz E., Edler R. Efficacy of immunising pigs against porcine circovirus type 2 at three or six weeks of age. Vet. Rec. 2008, 163:737-740.
8. De Jong J.C., De Ronde-Verloop F.M., Dorpema J.W. Testing of the strain identity of influenza vaccines by haemagglutination inhibition. J. Biol. Stand. 1982, 10:175-183.
9. Desrosiers R., Clark E., Tremblay D., Tremblay R., Polson D. Use of a one-dose subunit vaccine to prevent losses associated with porcine circovirus type 2. J. Swine Health Prod. 2009, 17:148-154.
10. Fachinger V., Bischoff R., Jedidia S.B., Saalmuller A., Elbers K. The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex. Vaccine 2008, 26:1488-1499.
11. Fenaux M., Opriessnig T., Halbur T., Elvinger F., Meng X.J. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs. J. Virol. 2004, 78:6297-6303.
12. Fort M., Sibila M., Allepuz A., Mateu E., Roerink F., Segales J. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Vaccine 2008, 26:1063-1071.
13. Fort M., Sibila M., Pérez-Martín E., Nofrarías M., Mateu E., Segalés J. One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model. Vaccine 2009, 27:4031-4037.
14. Fort M., Fernandes L.T., Nofrarías M., Díaz I., Sibila M., Pujols J., et al. Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets. Vet. Immunol. Immunopathol. 2009, 129:101-107.
15. Grau-Roma L., Hjulsager C.K., Sibila M., Kristensen C.S., Lopez-Soria S., Enoe C., et al. Infection, excretion and seroconversion dynamics of porcine circovirus type 2 (PCV2) in pigs from post-weaning multisystemic wasting syndrome (PMWS) affected farms in Spain and Denmark. Vet. Microbiol. 2009, 135:272-282.
16. Horlen K.P., Dritz S.S., Nietfeld J.C., Henry S.C., Hesse R.A., Oberst R., et al. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2. J. Am. Vet. Med. Assoc. 2008, 232:906-912.
17. Kawashima K., Katsuda K., Tsunemitsu H. Epidemiological investigation of the prevalence and features of postweaning multisystemic wasting syndrome in Japan. J. Vet. Diagn. Invest. 2007, 19:60-68.
18. Kimman T.G., Cornelissen L.A., Moormann R.J., Rebel J.M., Stockhofe-Zurwieden N. Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology. Vaccine 2009, 27:3704-3718.
19. King D., DuBois P., Painter T., Holck T., Edler R., Johnson C., et al. Biologic and economic benefits of controlling subclinical PCVAD with vaccination. Proceedings of the AASV Congress 2008, 159-162.
20. Kixmoller M., Ritzmann M., Eddicks M., Saalmuller A., Elbers K., Fachinger V. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2. Vaccine 2008, 26:3443-3451.
21. Kyriakis S.C., Bourtzi-Hatzopoulou E., Alexopoulos C., Kritas S.K., Polyzopoulou Z., Lekkas S., et al. Field evaluation of the effect of in-feed doxycycline for the control of ileitis in weaned piglets. J. Vet. Med. B: Infect. Dis. Vet. Public Health 2002, 49:317-321.
22. Labarque G., Reeth K.V., Nauwynck H., Drexler C., Van Gucht S., Pensaert M. Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy. Vaccine 2004, 22:4183-4190.
23. Martelli P., Cordioli P., Alborali L.G., Gozio S., De Angelis E., Ferrari L., Lombardi G., Borghetti P. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain. Vaccine 2007, 25:3400-3408.
24. Martelli P., Gozio S., Ferrari L., Rosina S., De Angelis E., Quintavalla C., et al. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: clinical protection and cell-mediated immunity. Vaccine 2009, 27:3788-3799.
25. Martelli P., Ferrari L., Morganti M., De Angelis E., Bonilauri P., Guazzetti S., Caleffi A., Borghetti P. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions. Vet. Microbiol. 2011, 149:339-351.
26. Oleksiewicz M., Botner A., Madsen K.G., Storgaard T. Sensitive detection and typing of porcine reproductive and respiratory syndrome virus by RT-PCR amplification of whole viral genes. Vet. Microbiol. 1998, 64:7-22.
27. Olvera A., Sibila M., Calsamiglia M., Segalés J., Domingo M. Comparison of porcine circovirus type 2 load in serum quantified by a real time PCR in postweaning multisystemic wasting syndrome and porcine dermatitis and nephropathy syndrome naturally affected pigs. J. Virol. Methods 2004, 117:75-80.
28. Opriessnig T., Thacker E.L., Yu S., Fenaux M., Meng X.J., Halbur P.G. Experimental reproduction of postweaning multisystemic wasting syndrome in pigs by dual infection with Mycoplasma hyopneumoniae and porcine circovirus type 2. Vet. Pathol. 2004, 41:624-640.
29. Opriessnig T., Meng X.J., Halbur P.G. Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. J. Vet. Diagn. Invest. 2007, 19:591-615.
30. Opriessnig T., Patterson A.R., Elsener J., Meng X.J., Halbur P.G. Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2. Clin. Vaccine Immunol. 2008, 15:397-401.
31. Opriessnig T., Madson D.M., Prickett J.R., Kuhar D., Lunney J.K., Elsener J., et al. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection. Vet. Microbiol. 2008, 131:103-114.
32. Opriessnig T., Patterson A.R., Madson D.M., Pal N., Halbur P.G. Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination. Vaccine 2009, 27:1002-1007.
33. Pallares F.J., Halbur P.G., Opriessnig T., Sorden S.D., Villar D., Janke B.H., et al. Porcine circovirus type 2 (PCV-2) coinfections in US field cases of postweaning multisystemic wasting syndrome (PMWS). J. Vet. Diagn. Invest. 2002, 14:515-519.
34. Pinheiro J.C., Bates D.M. Mixed-Effects Models in S and S-PLUS 2000, Springer, NY.
35. Pogranichniy R.M., Yoon K.J., Harms P.A., Sorden S.D., Daniels M. Case-control study on the association of porcine circovirus type 2 and other swine viral pathogens with postweaning multisystemic wasting syndrome. J. Vet. Diagn. Invest. 2002, 14:449-456.
36. Quintana J., Segalés J., Rosell C., Calsamiglia M., Rodriguez-Arrioja G.M., Chianini F., et al. Clinical and pathological observations on pigs with postweaning multisystemic wasting syndrome. Vet. Rec. 2001, 149:357-361.
37. R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2012 (ISBN 3-900051-07-0 - ). http://www.r-project.org/.
38. Rodríguez-Arrioja G.M., Segalés J., Balasch M., Rosell C., Quinta J., Folch J.M., et al. Serum antibodies to porcine circovirus type 1 (PCV-1) and type 2 (PCV-2) in pigs with and without postweaning multisystemic wasting syndrome (PMWS). Vet. Rec. 2000, 146:762-764.
39. Rose N., Larour G., Le Diguerher G., Eveno E., Jolly J.P., Blanchard P., et al. Risk factors for porcine post-weaning multisystemic wasting syndrome (PMWS) in 149 French farrow-to-finish herds. Prev. Vet. Med. 2003, 61:209-225.
40. Rosell C., Segalés J., Ramos-Vara J.A., Folch J.M., Rodriguez-Arrioja G.M., Duran C.O., et al. Identification of porcine circovirus in tissues of pigs with porcine dermatitis and nephropathy syndrome. Vet. Rec. 2000, 146:40-43.
41. Segalés J., Calsamiglia M., Rosell C., Soler M., Maldonado J., Martin M., et al. Porcine reproductive and respiratory syndrome virus (PRRSV) infection status in pigs naturally affected with post-weaning multisystemic wasting syndrome (PMWS) in Spain. Vet. Microbiol. 2002, 85:23-30.
42. Segalés J., Allan G.M., Domingo M. Porcine circovirus diseases. Anim. Health Res. Rev. 2005, 6:119-142.
43. Segalés J., Urniza A., Alegre A., Bru T., Crisci E., Nofrarías M., et al. A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) improves clinical, pathological and virological outcomes in postweaning multisystemic wasting syndrome affected farms. Vaccine 2009, 27:7313-7321.
44. Shen H.G., Beach N.M., Huang Y.W., Halbur P.G., Meng X.J., Opriessnig T. Comparison of commercial and experimental porcine circovirus type 2 (PCV2) vaccines using a triple challenge with PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and porcine parvovirus (PPV). Vaccine 2010, 28:5960-5966.
45. Sibila M., Calsamiglia M., Segalés J., Blanchard P., Badiella L., Le Dimna M., et al. Use of a polymerase chain reaction assay and an ELISA to monitor porcine circovirus type 2 infection in pigs from farms with and without postweaning multisystemic wasting syndrome. Am. J. Vet. Res. 2004, 65:88-92.
46. Sorden S.D. Update on porcine circovirus and postweaning multisystemic wasting syndrome (PMWS). J. Swine Health Prod. 2000, 8:133-136.
47. Straw B.E., Meuten D.J., Thacker B.J. Physical examination. Diseases of Swine 1999, 3-18. Blackwell Scientific Publications, Oxford. B.E. Straw, S. D'Allaire, W.L. Mengeling, D.J. Taylor (Eds.).
48. Suárez P., Zardoya R., Prieto C., Solana A., Tabarés E., Bautista J.M., Castro J.M. Direct detection of the porcine reproductive and respiratory syndrome (PRRS) virus by reverse polymerase chain reaction (RT-PCR). Arch. Virol. 1994, 135:89-99.
49. Tacker B., Wilson W., Francisco C., Schlueter R. Circumvent PCV vaccine: performance evaluation and serological studies update. Proceedings of the AASV Congress 2008, 153-156.
50. Therneau T.M., Grambsch P.M. Modeling Survival Data: Extending the Cox Model 2000, Springer, New York.
51. Wood S.N. Generalized Additive Models: An Introduction with R 2006, CRC/Chapman & Hall, Boca Raton, FL.